Thyroid-adrenal Pellet
NDC Package 55714-2565-1
Package Information
Thyroid-adrenal (adrenalinum, thyroidinum, aloe, calc. carb., chelidonium majus, conium, graphites, iodium, lachesis, lycopodium, lycopus virginicus, phytolacca, rhus toxicodendron, silicea, spongia, echinacea) pellets is formulated for associated symptoms such as rapid or sluggish metabolism, weight fluctuation, fatigue and hair loss. This formulation utilizes a pellet delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-2565.
Identification & Billing
Clinical Specifications
- ALOE 15 [hp_X]/g
- CHELIDONIUM MAJUS 15 [hp_X]/g
- CONIUM MACULATUM FLOWERING TOP 15 [hp_X]/g
- ECHINACEA, UNSPECIFIED 6 [hp_X]/g
- EPINEPHRINE 15 [hp_X]/g
- GRAPHITE 15 [hp_X]/g
- IODINE 15 [hp_X]/g
- LACHESIS MUTA VENOM 15 [hp_X]/g
- LYCOPODIUM CLAVATUM SPORE 15 [hp_X]/g
- LYCOPUS VIRGINICUS 15 [hp_X]/g
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 15 [hp_X]/g
- PHYTOLACCA AMERICANA ROOT 15 [hp_X]/g
- SILICON DIOXIDE 15 [hp_X]/g
- SPONGIA OFFICINALIS SKELETON, ROASTED 15 [hp_X]/g
- THYROID, UNSPECIFIED 15 [hp_X]/g
- TOXICODENDRON PUBESCENS LEAF 15 [hp_X]/g
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-2565 - Thyroid-adrenal
- 55714-2565-1 - 28 g in 1 BOTTLE, GLASS
- 55714-2565 - Thyroid-adrenal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-2565-1 identifies a specific commercial package of 28 g in 1 bottle, glass of Thyroid-adrenal, a human over the counter drug labeled by Newton Laboratories, Inc.. This pellet is formulated for oral use and contains aloe; chelidonium majus; conium maculatum flowering top; echinacea, unspecified; epinephrine; graphite; iodine; lachesis muta venom; lycopodium clavatum spore; lycopus virginicus; oyster shell calcium carbonate, crude; phytolacca americana root; silicon dioxide; spongia officinalis skeleton, roasted; thyroid, unspecified; toxicodendron pubescens leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on October 30, 2020. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714256501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.